These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, Old LJ. Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024 [Abstract] [Full Text] [Related]
7. Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Lehmann JM, Holzmann B, Breitbart EW, Schmiegelow P, Riethmüller G, Johnson JP. Cancer Res; 1987 Feb 01; 47(3):841-5. PubMed ID: 3542195 [Abstract] [Full Text] [Related]
10. Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody. Vogel AM, Esclamado RM. Cancer Res; 1988 Mar 01; 48(5):1286-94. PubMed ID: 3342407 [Abstract] [Full Text] [Related]
14. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype. Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L. Cancer Res; 2000 Oct 15; 60(20):5848-56. PubMed ID: 11059782 [Abstract] [Full Text] [Related]
15. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells. Harper JR, Bumol TF, Reisfeld RA. J Immunol; 1984 Apr 15; 132(4):2096-104. PubMed ID: 6199423 [Abstract] [Full Text] [Related]